Accession Number

Compounds with BENZENE fused to AZEPINES.

DrugDrug Description
LorazepamA short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and seizures.
TemazepamA short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and insomnia.
OlanzapineAn antipsychotic drug used in the management of schizophrenia, bipolar 1 disorder, and agitation associated with these disorders.
DiltiazemA calcium channel blocker used to treat hypertension and to manage chronic stable angina.
AlprazolamA triazolobenzodiazepine with intermediate onset commonly used to treat panic disorders and generalized anxiety in addition to anxiety associated with depression.
Clorazepic acidA benzodiazepine used to treat anxiety, partial seizures, and alcohol withdrawal.
GalantamineA cholinesterase inhibitor used to manage mild to moderate dementia associated with Alzheimer's Disease.
FenoldopamA dopamine D1 receptor agonist used for the short term management of hypertension.
DiazepamA long-acting benzodiazepine with rapid onset commonly used to treat panic disorders, severe anxiety, alcohol withdrawal, and seizures.
OxazepamAn intermediate-acting benzodiazepine with slow onset commonly used to treat panic disorders, severe anxiety, alcohol withdrawals, and insomnia.
ClonazepamA long-acting benzodiazepine with intermediate onset commonly used to treat panic disorders, severe anxiety, and seizures.
TalampanelFor the treatment of epilepsy.
RemimazolamAn ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures.
1,2-BenzodiazepineBenzodiazepine is under investigation for the prevention of Delirium and C.Surgical Procedure; Cardiac. Benzodiazepine has been investigated for the treatment of Obesity, Sleep Apnea, Obstructive, and Disorders of Gallbladder, Biliary...
RSV-604RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).
TolvaptanA selective vasopressin V2-receptor antagonist to slow kidney function decline in patients at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Also used to treat hypervolemic and euvolemic hyponatremia.
IvabradineA HCN channel blocker used to reduce the risk of hospitalization for worsening heart failure in adult patients and for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy in pediatric patients.
BMS-986115BMS-986115 has been used in trials studying the treatment of Various Advanced Cancer.
AdinazolamFor the treatment of anxiety and status epilepticus.
HalazepamUsed to relieve anxiety, nervousness, and tension associated with anxiety disorders.
VareniclineA partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation.
HaloxazolamNot Available
CamazepamCamazepam has been used in placebo controlled studies for the treatment of patients suffering from anxiety and depression.
DelorazepamA benzodiazepine used to manage severe anxiety disorders and insomnia.
Ethyl loflazepateNot Available
CloxazolamUsed primarily as an anti-anxiety agent. Typically used short term, and may be given as a single dose of up to 100mcg/kg to reduce anxiety and tension experienced prior to...
BromazepamA short-acting benzodiazepine with intermediate onset commonly used to treat panic disorders and severe anxiety.
FludiazepamUsed for the short-term treatment of anxiety disorders.
KetazolamA long-acting benzodiazepine used to manage anxiety and insomnia.
QuazepamA long-acting benzodiazepine used to manage insomnia.
CinolazepamA benzodiazepine used to manage severe and debilitating forms of sleep disorders of various origins in adults.
EVT 201Investigated for use/treatment in insomnia.
TarazepideInvestigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
S-8510Investigated for use/treatment in alzheimer's disease and dementia.
DextofisopamInvestigated for use/treatment in irritable bowel syndrome (IBS).
R-82913Not Available
TofisopamFor the treatment of anxiety and alcohol withdrawal.
AptazapineInvestigated for the treatment of depression.
EvacetrapibEvacetrapib has been used in trials studying the basic science and treatment of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Hepatic Insufficiency, and Cardiovascular Disease.
Vadastuximab talirineVadastuximab Talirine has been used in trials studying the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.
SJG-136SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and Secondary Myelodysplastic Syndromes,...
OsugacestatOsugacestat (BMS-906024) has been used in trials studying the treatment of Cancer, Lymphoblastic Leukemia, Acute T-cell, and Precursor T-Cell Lymphoblastic Lymphoma.
BMS-214662BMS-214662 has been used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and Adult Acute...
GI-181771XGski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
NetazepideNetazepide has been used in trials studying the prevention and treatment of Dyspepsia, Hypergastrinaemia, Barrett's Esophagus, ECL-cell Hyperplasia, and Rebound Hyperacidity, among others.
IndiplonIndiplon has been used in trials studying the treatment of Insomnia and Depression.
PF-477736PF-00477736 has been used in trials studying the treatment of Neoplasms.
CE-326597CE-326,597 has been used in trials studying the treatment of Obesity.
Rovalpituzumab tesirineRovalpituzumab Tesirine has been used in trials studying the treatment of GLIOBLASTOMA, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer, among others.
TetrazepamNot Annotated
PinazepamA benzodiazepine indicated in the treatment of anxiety and severe insomnia.
LoprazolamLoprazolam is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent...
DoxefazepamNot Annotated
CinazepamNot Annotated
ClonazolamNot Annotated
PyrazolamNot Annotated
BalovaptanBalovaptan is under investigation in clinical trial NCT01793441 (A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)).
MexazolamA benzodiazepine indicated to treat anxiety with or without psychoneurotic conditions.
OxazolamNot Annotated
Ro 24-7429Ro 24-7429 is under investigation in clinical trial NCT00002314 (A Study of Ro 24-7429 in Patients With Hiv-related Kaposi's Sarcoma).
Loncastuximab tesirineAn antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas.
MolibresibMolibresib is under investigation in clinical trial NCT01943851 (A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory...
OdevixibatAn ileal sodium/bile acid cotransporter inhibitor indicated in the treatment of pruritus in patients with progressive familial intrahepatic cholestasis.
ClobazamA benzodiazepine used as adjunct treatment in seizures associated with Lennox-Gastaut syndrome.
ChlordiazepoxideA benzodiazepine used to treat the withdrawal symptoms of acute alcoholism, to treat preoperative anxiety, and to treat anxiety over a short term period.
PirenzepineAn antimuscarinic agent used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
FlurazepamA long-acting benzodiazepine with a rapid onset of action that is commonly used to treat insomnia.
TriazolamA benzodiazepine used for short term treatment of insomnia.
FlumazenilA benzodiazepine antagonist that is used for the complete or partial reversal of the sedative effects caused by benzodiazepines in various clinical settings, such as induced general anesthesia for diagnostic and therapeutic procedures.
EstazolamA benzodiazepine used for the short-term management of insomnia.
FlunitrazepamA benzodiazepine used to manage anxiety disorders and insomnia.
PrazepamA benzodiazepine used to manage more severe forms of anxiety disorders.
NitrazepamA long-acting benzodiazepine with intermediate onset commonly used to treat panic disorders, severe anxiety, insomnia, and seizures.
Omacetaxine mepesuccinateA cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors.
EtizolamA thienodiazepine derivative used to treat anxiety and insomnia.
MedazepamA long-acting benzodiazepine used for its sedative and anxiolytic properties.
LormetazepamA benzodiazepine indicated in the treatment of anxiety and the induction of anesthesia.
NordazepamA benzodiazepine indicated in the treatment of insomnia.
Oxazepam acetateNot Annotated
IomazenilIomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
NorclobazamNot Annotated
LixivaptanInvestigated for use/treatment in hyponatremia and congestive heart failure.
Drugs & Drug Targets
LorazepamUDP-glucuronosyltransferase 2B15enzyme
LorazepamGABA(A) Receptortarget
LorazepamCytochrome P450 3A4enzyme
LorazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
TemazepamCytochrome P450 3A4enzyme
TemazepamCytochrome P450 2B6enzyme
TemazepamCytochrome P450 2C9enzyme
TemazepamGABA(A) Receptortarget
TemazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
OlanzapineDopamine D1 receptortarget
OlanzapineMuscarinic acetylcholine receptor M1target
OlanzapineMuscarinic acetylcholine receptor M3target
Olanzapine5-hydroxytryptamine receptor 2Atarget
OlanzapineDopamine D4 receptortarget
OlanzapineHistamine H1 receptortarget
OlanzapineMuscarinic acetylcholine receptor M4target
OlanzapineMuscarinic acetylcholine receptor M2target
OlanzapineDopamine D2 receptortarget
Olanzapine5-hydroxytryptamine receptor 2Ctarget
OlanzapineDopamine D3 receptortarget
OlanzapineAlpha-1B adrenergic receptortarget
OlanzapineCytochrome P450 1A2enzyme
Olanzapine5-hydroxytryptamine receptor 3Atarget
Olanzapine5-hydroxytryptamine receptor 6target
OlanzapineAlpha-1A adrenergic receptortarget
OlanzapineDopamine D5 receptortarget
OlanzapineSerum albumincarrier
OlanzapineAlpha-1-acid glycoprotein 1carrier
OlanzapineDimethylaniline monooxygenase [N-oxide-forming] 3enzyme
OlanzapineCytochrome P450 2D6enzyme
OlanzapineP-glycoprotein 1transporter
OlanzapineCytochrome P450 2C19enzyme
OlanzapineD(1) dopamine receptortarget
OlanzapineBeta adrenergic receptortarget
Olanzapine5-hydroxytryptamine receptor 1target
OlanzapineGABA(A) Receptor Benzodiazepine Binding Sitetarget
OlanzapineCytochrome P450 2C9enzyme
OlanzapineUDP-glucuronosyltransferase 1-4enzyme
OlanzapineCytochrome P450 3A4enzyme
OlanzapineCytochrome P450 3A Subfamilyenzyme
DiltiazemVoltage-dependent calcium channel gamma-1 subunittarget
DiltiazemCytochrome P450 3A4enzyme
DiltiazemCytochrome P450 2C19enzyme
DiltiazemCytochrome P450 2D6enzyme
DiltiazemCytochrome P450 3A5enzyme
DiltiazemCytochrome P450 3A7enzyme
DiltiazemP-glycoprotein 1transporter
DiltiazemCytochrome P450 2C8enzyme
DiltiazemSerum albumincarrier
DiltiazemAlpha-1-acid glycoprotein 1carrier
DiltiazemVoltage-dependent L-type calcium channel subunit alpha-1Ctarget
AlprazolamCytochrome P450 3A4enzyme
AlprazolamCytochrome P450 2C9enzyme
AlprazolamCytochrome P450 3A5enzyme
AlprazolamCytochrome P450 3A7enzyme
AlprazolamGABA(A) Receptortarget
AlprazolamSerum albumincarrier
Alprazolamalpha1-acid glycoproteincarrier
AlprazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
Clorazepic acidCytochrome P450 3A4enzyme
Clorazepic acidGABA(A) Receptortarget
Clorazepic acidGABA(A) Receptor Benzodiazepine Binding Sitetarget
GalantamineCytochrome P450 3A4enzyme
GalantamineCytochrome P450 2D6enzyme
GalantamineP-glycoprotein 1transporter
GalantamineNeuronal acetylcholine receptor subunit alpha-7target
GalantamineMuscle nicotinic acetylcholine receptortarget
FenoldopamDopamine D5 receptortarget
FenoldopamDopamine D1 receptortarget
FenoldopamAlpha-2B adrenergic receptortarget
FenoldopamAlpha-2C adrenergic receptortarget
FenoldopamAlpha-2A adrenergic receptortarget
FenoldopamAlpha-1B adrenergic receptortarget
FenoldopamAlpha-1D adrenergic receptortarget
FenoldopamAlpha-1A adrenergic receptortarget
DiazepamCytochrome P450 3A4enzyme
DiazepamSerum albumincarrier
DiazepamCytochrome P450 2C9enzyme
DiazepamCytochrome P450 2C19enzyme
DiazepamCytochrome P450 3A5enzyme
DiazepamCytochrome P450 3A7enzyme
DiazepamP-glycoprotein 1transporter
DiazepamCytochrome P450 2B6enzyme
DiazepamProstaglandin G/H synthase 1enzyme
DiazepamCytochrome P450 2C18enzyme
DiazepamCytochrome P450 2C8enzyme
DiazepamGABA(A) Receptortarget
DiazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
OxazepamUDP-glucuronosyltransferase 2B15enzyme
OxazepamUDP-glucuronosyltransferase 2B7enzyme
OxazepamUDP-glucuronosyltransferase 1-9enzyme
OxazepamGABA(A) Receptortarget
OxazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
OxazepamSerum albumincarrier
ClonazepamCytochrome P450 3A4enzyme
ClonazepamSerum albumincarrier
ClonazepamCytochrome P450 2E1enzyme
ClonazepamArylamine N-acetyltransferase 2enzyme
ClonazepamGABA(A) Receptortarget
ClonazepamNuclear receptor subfamily 1 group I member 2target
ClonazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
TalampanelGlutamate receptor 1target
TalampanelGlutamate receptor 2target
TalampanelGlutamate receptor 3target
TalampanelGlutamate receptor 4target
RemimazolamLiver carboxylesterase 1enzyme
RemimazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
RemimazolamGABA(A) Receptortarget
RemimazolamSerum albumincarrier
1,2-BenzodiazepineCytochrome P450 3A4enzyme
1,2-BenzodiazepineGABA(A) Receptortarget
1,2-BenzodiazepineGABA(A) Receptor Benzodiazepine Binding Sitetarget
TolvaptanVasopressin V2 receptortarget
TolvaptanCytochrome P450 3A4enzyme
TolvaptanP-glycoprotein 1transporter
TolvaptanVasopressin V1a receptortarget
IvabradineCytochrome P450 3A4enzyme
IvabradinePotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2target
AdinazolamCytochrome P450 2C19enzyme
AdinazolamCytochrome P450 3A4enzyme
AdinazolamGABA(A) Receptortarget
AdinazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
HalazepamGABA(A) Receptortarget
HalazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
VareniclineNeuronal acetylcholine receptor subunit alpha-4target
VareniclineNeuronal acetylcholine receptor subunit alpha-7target
VareniclineNeuronal acetylcholine receptor subunit alpha-3target
VareniclineNeuronal acetylcholine receptor subunit alpha-6target
VareniclineNeuronal acetylcholine receptor subunit beta-2target
VareniclineSolute carrier family 22 member 2transporter
CamazepamGABA(A) Receptortarget
CamazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
DelorazepamGABA(A) Receptortarget
DelorazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
Ethyl loflazepateGABA(A) Receptortarget
Ethyl loflazepateGABA(A) Receptor Benzodiazepine Binding Sitetarget
CloxazolamGABA(A) Receptortarget
CloxazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
BromazepamCytochrome P450 1A2enzyme
BromazepamCytochrome P450 2C19enzyme
BromazepamCytochrome P450 2E1enzyme
BromazepamGABA(A) Receptortarget
BromazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
FludiazepamGamma-aminobutyric acid receptor subunit alpha-2target
FludiazepamGamma-aminobutyric acid receptor subunit alpha-1target
FludiazepamGamma-aminobutyric acid receptor subunit alpha-3target
FludiazepamGamma-aminobutyric acid receptor subunit alpha-5target
FludiazepamGamma-aminobutyric acid receptor subunit gamma-1target
FludiazepamGamma-aminobutyric acid receptor subunit gamma-2target
FludiazepamGamma-aminobutyric acid receptor subunit gamma-3target
FludiazepamGamma-aminobutyric acid receptor subunit beta-1target
FludiazepamGamma-aminobutyric acid receptor subunit beta-2target
FludiazepamGamma-aminobutyric acid receptor subunit beta-3target
FludiazepamGamma-aminobutyric acid receptor subunit deltatarget
FludiazepamGamma-aminobutyric acid receptor subunit epsilontarget
FludiazepamGamma-aminobutyric acid receptor subunit pitarget
FludiazepamGamma-aminobutyric acid receptor subunit rho-1target
FludiazepamGamma-aminobutyric acid receptor subunit rho-2target
FludiazepamGamma-aminobutyric acid receptor subunit rho-3target
KetazolamCytochrome P450 3A4enzyme
KetazolamP-glycoprotein 1transporter
KetazolamSerum albumincarrier
KetazolamGABA(A) Receptortarget
KetazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
QuazepamCytochrome P450 2C19enzyme
QuazepamCytochrome P450 2C9enzyme
QuazepamCytochrome P450 3A4enzyme
QuazepamGABA(A) Receptortarget
QuazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
CinolazepamGABA(A) Receptortarget
CinolazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
R-82913Gag-Pol polyproteintarget
R-82913Gag-Pol polyproteintarget
TofisopamcAMP-specific 3',5'-cyclic phosphodiesterase 4Atarget
TofisopamcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
TofisopamcGMP-inhibited 3',5'-cyclic phosphodiesterase Atarget
TofisopamcGMP-dependent 3',5'-cyclic phosphodiesterasetarget
TofisopamCytochrome P450 3A4enzyme
PF-477736Serine/threonine-protein kinase Chk1target
PinazepamGABA(A) Receptortarget
PinazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
LoprazolamGABA(A) Receptortarget
LoprazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
DoxefazepamGABA(A) Receptortarget
DoxefazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
CinazepamGABA(A) Receptortarget
CinazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
MexazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
MexazolamCytochrome P450 3A4enzyme
MexazolamGABA(A) Receptortarget
Loncastuximab tesirineB-lymphocyte antigen CD19target
Loncastuximab tesirineP-glycoprotein 1transporter
Loncastuximab tesirineCytochrome P450 3A4enzyme
Loncastuximab tesirineCytochrome P450 3A5enzyme
OdevixibatIleal sodium/bile acid cotransportertarget
OdevixibatP-glycoprotein 1transporter
ClobazamCytochrome P450 2C19enzyme
ClobazamCytochrome P450 3A4enzyme
ClobazamCytochrome P450 2B6enzyme
ClobazamCytochrome P450 2C18enzyme
ClobazamP-glycoprotein 1transporter
ClobazamGABA(A) Receptortarget
ClobazamCytochrome P450 2D6enzyme
ClobazamGABA(A) Receptor Benzodiazepine Binding Sitetarget
ClobazamSerum albumincarrier
ClobazamAlpha-1-acid glycoprotein 1carrier
ClobazamCytochrome P450 2C9enzyme
ClobazamUDP-glucuronosyltransferase 1-4enzyme
ClobazamUDP-glucuronosyltransferase 1-6enzyme
ClobazamUDP-glucuronosyltransferase 2B4enzyme
ClobazamUDP-glucuronosyltransferase 1-1enzyme
ClobazamCytochrome P450 1A2enzyme
ClobazamCytochrome P450 2C8enzyme
ClobazamCytochrome P450 3A5enzyme
ClobazamCytochrome P450 3A7enzyme
ChlordiazepoxideGABA(A) Receptortarget
ChlordiazepoxideGABA(A) Receptor Benzodiazepine Binding Sitetarget
ChlordiazepoxideCytochrome P450 3A4enzyme
PirenzepineMuscarinic acetylcholine receptor M1target
FlurazepamCytochrome P450 3A4enzyme
FlurazepamP-glycoprotein 1transporter
FlurazepamCytochrome P450 2E1enzyme
FlurazepamCytochrome P450 2A6enzyme
FlurazepamSolute carrier family 22 member 2transporter
FlurazepamGABA(A) Receptortarget
FlurazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
TriazolamCytochrome P450 3A4enzyme
TriazolamCytochrome P450 3A5enzyme
TriazolamCytochrome P450 3A7enzyme
TriazolamCytochrome P450 2C8enzyme
TriazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
TriazolamGABA(A) Receptortarget
FlumazenilGamma-aminobutyric acid receptor subunit alpha-1target
FlumazenilGamma-aminobutyric acid receptor subunit gamma-2target
FlumazenilGamma-aminobutyric acid receptor subunit alpha-5target
FlumazenilGABA(A) Receptortarget
EstazolamCytochrome P450 3A4enzyme
EstazolamGABA(A) Receptortarget
EstazolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
FlunitrazepamCytochrome P450 2C19enzyme
FlunitrazepamUDP-glucuronosyltransferase 2B7enzyme
FlunitrazepamCytochrome P450 2A6enzyme
FlunitrazepamCytochrome P450 2B6enzyme
FlunitrazepamCytochrome P450 2C9enzyme
FlunitrazepamCytochrome P450 3A4enzyme
FlunitrazepamCytochrome P450 2E1enzyme
FlunitrazepamUDP-glucuronosyltransferase 1-1enzyme
FlunitrazepamUDP-glucuronosyltransferase 1-3enzyme
FlunitrazepamGABA(A) Receptortarget
FlunitrazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
PrazepamCytochrome P450 3A4enzyme
PrazepamGABA(A) Receptortarget
PrazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
NitrazepamSodium channel protein type 1 subunit alphatarget
NitrazepamCytochrome P450 3A4enzyme
NitrazepamCytochrome P450 2E1enzyme
NitrazepamGABA(A) Receptortarget
NitrazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
Omacetaxine mepesuccinate50S ribosomal protein L2target
Omacetaxine mepesuccinate60S ribosomal protein L3target
EtizolamCytochrome P450 3A4enzyme
EtizolamCytochrome P450 2C18enzyme
EtizolamCytochrome P450 2C19enzyme
EtizolamPlatelet-activating factor receptortarget
EtizolamGABA(A) Receptortarget
EtizolamGABA(A) Receptor Benzodiazepine Binding Sitetarget
MedazepamGABA(A) Receptortarget
MedazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
LormetazepamGABA(A) Receptortarget
LormetazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
NordazepamGABA(A) Receptortarget
NordazepamGABA(A) Receptor Benzodiazepine Binding Sitetarget
Oxazepam acetateGABA(A) Receptortarget
Oxazepam acetateGABA(A) Receptor Benzodiazepine Binding Sitetarget